Global CBD Oil Market

CBD Oil Comprehensive Study by Type (Marijuana-Derived CBD Oil Products, Hemp-Derived CBD Oil Products), Application (Medical, Recreational), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), Disease Indication (Anxiety, Fibromyalgia (FM), Diabetes, Others) Players and Region - Global Market Outlook to 2030

CBD Oil Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 30%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Market Overview:
Cannabidiol (CBD) is mainly found in the cannabis plant. It is naturally occurring ingredients which can be extracted & mixed with a carrier oil to produce CBD oil. it is mixed with hemp seed or coconut. CBD oil can be derived from two different species of cannabinoids such as marijuana and hemp. Rising awareness about the health benefits of CBD is expected to drive the growth of the market. The demand for CBD oil has been increased on continue basis. it is mainly due to their ability to cure multiple diseases and ailments of the human body. CBD oil has anti-inflammatory property hence it is used in the treatment of Alzheimer's disease. It also benefits in the treatment of epilepsy and mental health disorders. The adoption rate of CBD oil is increasing owing to its drug withdrawal. It is able to suppress growth of cancer cells to prevent cancer. Thus, increasing demand as effective pharmaceutical ingredients and health benefits associated with it has impacted on the demand for CBD oil in positive manner.

Asia-Pacific is projected to be the fastest-growing market, expanding at a CAGR of % from 2023 to 2030.

AttributesDetails
Study Period2018-2030
Base Year2023
Forecast Period2024-2030
Historical Period2018-2023
UnitValue (USD Million)
Key Companies ProfiledENDOCA BV (Netherlands), Isodiol International Inc. (Canada), Medical Marijuana Inc. (United States), Aurora Cannabis Inc. (Canada), CBD American Shaman (United States), Elixinol LLC (United States), FOLIUM BIOSCIENCES (United States), Freedom Leaf Inc. (United States), NuLeaf Naturals, LLC. (United States) and Charlotte's Web (CWB Holdings, Inc.) (United States)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region or narrow down segments in the final scope subject to feasibility


AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics of major and emerging geographies across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.

Key Players of CBD Oil Market Study:
ENDOCA BV (Netherlands), Isodiol International Inc. (Canada), Medical Marijuana Inc. (United States), Aurora Cannabis Inc. (Canada), CBD American Shaman (United States), Elixinol LLC (United States), FOLIUM BIOSCIENCES (United States), Freedom Leaf Inc. (United States), NuLeaf Naturals, LLC. (United States) and Charlotte's Web (CWB Holdings, Inc.) (United States)

CBD Oil Market Segment Analysis
ScopeSub-Segments
Application / End UserMedical and Recreational
TypeMarijuana-Derived CBD Oil Products and Hemp-Derived CBD Oil Products
Distribution ChannelHospital Pharmacies,Retail Pharmacies,Online Pharmacies,Others
Disease Indication Anxiety,Fibromyalgia (FM),Diabetes,Others


The Anxiety segment is expected to command the largest share of the Global CBD Oil market

Influencing Trend:
Increasing Legalization of Cannabis-Based Products

Market Growth Drivers:
Growing Awareness Regarding Health benefits of CBD oil and Globally Increasing Millennial Population and Rising E-Commerce Industry

Challenges:
High price

Restraints:
High Cost of the Product

Opportunities:
Emerging Markets and The advent of advanced cultivation processes

Some of the other players that are also part of study are Green Roads Wellness (United States), Kazmira LLC (Orochem Technologies) (United States), CV Sciences, Inc. (United States), Cannoid LLC (United States) and Canopy Growth Corporation (Canada). The Global CBD Oil market is gaining huge competition due to involvement of Global companies that constantly invest in research & development to meet market expectation with new innovation.

Latest Industry Highlights:
In March 2024, Avicanna Inc. launched focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products is pleased to announce the launch of RHO Phyto Micro Drop 100, a 10% CBD (THC free), proprietary oral formulation in Canada. RHO Phyto Micro Drop 100 is designed to deliver enhanced absorption of cannabinoids through an inverted emulsion technology.
In September 2023, Aurora Cannabis Inc. announced an expansion of its hemp-derived CBD portfolio into Brazil. In partnership with Herbarium, the leading Brazilian company in herbal medicine, Aurora will launch the company's full-spectrum, single-source 3% CBD oil, under the Herbarium brand. Now available under the direction of medical doctors, patients across Brazil have access to high quality CBD as part of their healthcare.
In the United States, Food and Drug Administration approved the CBD drug Epidiolex for treatment of two epilepsy disorders. Also, The U.S. Drug Enforcement Administration (DEA) has assigned Epidiolex a Schedule V classification as well as non-Epidiolex CBD remains a Schedule I drug prohibited for any usage. In 2018, the World Health Organization recommended that CBD remain unscheduled. CBD is not scheduled under any United Nations drug control treaties.

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global CBD Oil market.
In order to reach an exhaustive list of functional and relevant players, various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep into important geographies by players, and a thorough validation test is conducted to reach the most relevant players for survey in CBD Oil market.
Identification of total players or companies operating in the global market which is further concentrated to fewer or most impacting players which are considered under the report’s scope. In order to make a priority list sorting is done based on revenue generated based on the latest reporting with the help of paid databases such as Factiva, Bloomberg, etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes CBD Oil Products manufacturers, Raw material suppliers, Hospitals, Government and research organizations, Distribution consultancies and End users.

This helps us to gather the data for the players’ revenue, operating cycle and expense, profit along with product or service growth, etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that include Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, Annual reports, press releases etc.

Report Objectives / Segmentation Covered

By Type
  • Marijuana-Derived CBD Oil Products
  • Hemp-Derived CBD Oil Products
By Application
  • Medical
  • Recreational
By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

By Disease Indication
  • Anxiety
  • Fibromyalgia (FM)
  • Diabetes
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Awareness Regarding Health benefits of CBD oil
      • 3.2.2. Globally Increasing Millennial Population and Rising E-Commerce Industry
    • 3.3. Market Challenges
      • 3.3.1. High price
    • 3.4. Market Trends
      • 3.4.1. Increasing Legalization of Cannabis-Based Products
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global CBD Oil, by Type, Application, Distribution Channel, Disease Indication and Region (value, volume and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global CBD Oil (Value)
      • 5.2.1. Global CBD Oil by: Type (Value)
        • 5.2.1.1. Marijuana-Derived CBD Oil Products
        • 5.2.1.2. Hemp-Derived CBD Oil Products
      • 5.2.2. Global CBD Oil by: Application (Value)
        • 5.2.2.1. Medical
        • 5.2.2.2. Recreational
      • 5.2.3. Global CBD Oil by: Distribution Channel (Value)
        • 5.2.3.1. Hospital Pharmacies
        • 5.2.3.2. Retail Pharmacies
        • 5.2.3.3. Online Pharmacies
        • 5.2.3.4. Others
      • 5.2.4. Global CBD Oil Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global CBD Oil (Volume)
      • 5.3.1. Global CBD Oil by: Type (Volume)
        • 5.3.1.1. Marijuana-Derived CBD Oil Products
        • 5.3.1.2. Hemp-Derived CBD Oil Products
      • 5.3.2. Global CBD Oil by: Application (Volume)
        • 5.3.2.1. Medical
        • 5.3.2.2. Recreational
      • 5.3.3. Global CBD Oil by: Distribution Channel (Volume)
        • 5.3.3.1. Hospital Pharmacies
        • 5.3.3.2. Retail Pharmacies
        • 5.3.3.3. Online Pharmacies
        • 5.3.3.4. Others
      • 5.3.4. Global CBD Oil Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global CBD Oil (Price)
      • 5.4.1. Global CBD Oil by: Type (Price)
  • 6. CBD Oil: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. ENDOCA BV (Netherlands)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Isodiol International Inc. (Canada)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Medical Marijuana Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Aurora Cannabis Inc. (Canada)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. CBD American Shaman (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Elixinol LLC (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. FOLIUM BIOSCIENCES (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Freedom Leaf Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. NuLeaf Naturals, LLC. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Charlotte's Web (CWB Holdings, Inc.) (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global CBD Oil Sale, by Type, Application, Distribution Channel, Disease Indication and Region (value, volume and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global CBD Oil (Value)
      • 7.2.1. Global CBD Oil by: Type (Value)
        • 7.2.1.1. Marijuana-Derived CBD Oil Products
        • 7.2.1.2. Hemp-Derived CBD Oil Products
      • 7.2.2. Global CBD Oil by: Application (Value)
        • 7.2.2.1. Medical
        • 7.2.2.2. Recreational
      • 7.2.3. Global CBD Oil by: Distribution Channel (Value)
        • 7.2.3.1. Hospital Pharmacies
        • 7.2.3.2. Retail Pharmacies
        • 7.2.3.3. Online Pharmacies
        • 7.2.3.4. Others
      • 7.2.4. Global CBD Oil Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global CBD Oil (Volume)
      • 7.3.1. Global CBD Oil by: Type (Volume)
        • 7.3.1.1. Marijuana-Derived CBD Oil Products
        • 7.3.1.2. Hemp-Derived CBD Oil Products
      • 7.3.2. Global CBD Oil by: Application (Volume)
        • 7.3.2.1. Medical
        • 7.3.2.2. Recreational
      • 7.3.3. Global CBD Oil by: Distribution Channel (Volume)
        • 7.3.3.1. Hospital Pharmacies
        • 7.3.3.2. Retail Pharmacies
        • 7.3.3.3. Online Pharmacies
        • 7.3.3.4. Others
      • 7.3.4. Global CBD Oil Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global CBD Oil (Price)
      • 7.4.1. Global CBD Oil by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. CBD Oil: by Type(USD Million)
  • Table 2. CBD Oil Marijuana-Derived CBD Oil Products , by Region USD Million (2018-2023)
  • Table 3. CBD Oil Hemp-Derived CBD Oil Products , by Region USD Million (2018-2023)
  • Table 4. CBD Oil: by Application(USD Million)
  • Table 5. CBD Oil Medical , by Region USD Million (2018-2023)
  • Table 6. CBD Oil Recreational , by Region USD Million (2018-2023)
  • Table 7. CBD Oil: by Distribution Channel(USD Million)
  • Table 8. CBD Oil Hospital Pharmacies , by Region USD Million (2018-2023)
  • Table 9. CBD Oil Retail Pharmacies , by Region USD Million (2018-2023)
  • Table 10. CBD Oil Online Pharmacies , by Region USD Million (2018-2023)
  • Table 11. CBD Oil Others , by Region USD Million (2018-2023)
  • Table 12. South America CBD Oil, by Country USD Million (2018-2023)
  • Table 13. South America CBD Oil, by Type USD Million (2018-2023)
  • Table 14. South America CBD Oil, by Application USD Million (2018-2023)
  • Table 15. South America CBD Oil, by Distribution Channel USD Million (2018-2023)
  • Table 16. South America CBD Oil, by Disease Indication USD Million (2018-2023)
  • Table 17. Brazil CBD Oil, by Type USD Million (2018-2023)
  • Table 18. Brazil CBD Oil, by Application USD Million (2018-2023)
  • Table 19. Brazil CBD Oil, by Distribution Channel USD Million (2018-2023)
  • Table 20. Brazil CBD Oil, by Disease Indication USD Million (2018-2023)
  • Table 21. Argentina CBD Oil, by Type USD Million (2018-2023)
  • Table 22. Argentina CBD Oil, by Application USD Million (2018-2023)
  • Table 23. Argentina CBD Oil, by Distribution Channel USD Million (2018-2023)
  • Table 24. Argentina CBD Oil, by Disease Indication USD Million (2018-2023)
  • Table 25. Rest of South America CBD Oil, by Type USD Million (2018-2023)
  • Table 26. Rest of South America CBD Oil, by Application USD Million (2018-2023)
  • Table 27. Rest of South America CBD Oil, by Distribution Channel USD Million (2018-2023)
  • Table 28. Rest of South America CBD Oil, by Disease Indication USD Million (2018-2023)
  • Table 29. Asia Pacific CBD Oil, by Country USD Million (2018-2023)
  • Table 30. Asia Pacific CBD Oil, by Type USD Million (2018-2023)
  • Table 31. Asia Pacific CBD Oil, by Application USD Million (2018-2023)
  • Table 32. Asia Pacific CBD Oil, by Distribution Channel USD Million (2018-2023)
  • Table 33. Asia Pacific CBD Oil, by Disease Indication USD Million (2018-2023)
  • Table 34. China CBD Oil, by Type USD Million (2018-2023)
  • Table 35. China CBD Oil, by Application USD Million (2018-2023)
  • Table 36. China CBD Oil, by Distribution Channel USD Million (2018-2023)
  • Table 37. China CBD Oil, by Disease Indication USD Million (2018-2023)
  • Table 38. Japan CBD Oil, by Type USD Million (2018-2023)
  • Table 39. Japan CBD Oil, by Application USD Million (2018-2023)
  • Table 40. Japan CBD Oil, by Distribution Channel USD Million (2018-2023)
  • Table 41. Japan CBD Oil, by Disease Indication USD Million (2018-2023)
  • Table 42. India CBD Oil, by Type USD Million (2018-2023)
  • Table 43. India CBD Oil, by Application USD Million (2018-2023)
  • Table 44. India CBD Oil, by Distribution Channel USD Million (2018-2023)
  • Table 45. India CBD Oil, by Disease Indication USD Million (2018-2023)
  • Table 46. South Korea CBD Oil, by Type USD Million (2018-2023)
  • Table 47. South Korea CBD Oil, by Application USD Million (2018-2023)
  • Table 48. South Korea CBD Oil, by Distribution Channel USD Million (2018-2023)
  • Table 49. South Korea CBD Oil, by Disease Indication USD Million (2018-2023)
  • Table 50. Taiwan CBD Oil, by Type USD Million (2018-2023)
  • Table 51. Taiwan CBD Oil, by Application USD Million (2018-2023)
  • Table 52. Taiwan CBD Oil, by Distribution Channel USD Million (2018-2023)
  • Table 53. Taiwan CBD Oil, by Disease Indication USD Million (2018-2023)
  • Table 54. Australia CBD Oil, by Type USD Million (2018-2023)
  • Table 55. Australia CBD Oil, by Application USD Million (2018-2023)
  • Table 56. Australia CBD Oil, by Distribution Channel USD Million (2018-2023)
  • Table 57. Australia CBD Oil, by Disease Indication USD Million (2018-2023)
  • Table 58. Rest of Asia-Pacific CBD Oil, by Type USD Million (2018-2023)
  • Table 59. Rest of Asia-Pacific CBD Oil, by Application USD Million (2018-2023)
  • Table 60. Rest of Asia-Pacific CBD Oil, by Distribution Channel USD Million (2018-2023)
  • Table 61. Rest of Asia-Pacific CBD Oil, by Disease Indication USD Million (2018-2023)
  • Table 62. Europe CBD Oil, by Country USD Million (2018-2023)
  • Table 63. Europe CBD Oil, by Type USD Million (2018-2023)
  • Table 64. Europe CBD Oil, by Application USD Million (2018-2023)
  • Table 65. Europe CBD Oil, by Distribution Channel USD Million (2018-2023)
  • Table 66. Europe CBD Oil, by Disease Indication USD Million (2018-2023)
  • Table 67. Germany CBD Oil, by Type USD Million (2018-2023)
  • Table 68. Germany CBD Oil, by Application USD Million (2018-2023)
  • Table 69. Germany CBD Oil, by Distribution Channel USD Million (2018-2023)
  • Table 70. Germany CBD Oil, by Disease Indication USD Million (2018-2023)
  • Table 71. France CBD Oil, by Type USD Million (2018-2023)
  • Table 72. France CBD Oil, by Application USD Million (2018-2023)
  • Table 73. France CBD Oil, by Distribution Channel USD Million (2018-2023)
  • Table 74. France CBD Oil, by Disease Indication USD Million (2018-2023)
  • Table 75. Italy CBD Oil, by Type USD Million (2018-2023)
  • Table 76. Italy CBD Oil, by Application USD Million (2018-2023)
  • Table 77. Italy CBD Oil, by Distribution Channel USD Million (2018-2023)
  • Table 78. Italy CBD Oil, by Disease Indication USD Million (2018-2023)
  • Table 79. United Kingdom CBD Oil, by Type USD Million (2018-2023)
  • Table 80. United Kingdom CBD Oil, by Application USD Million (2018-2023)
  • Table 81. United Kingdom CBD Oil, by Distribution Channel USD Million (2018-2023)
  • Table 82. United Kingdom CBD Oil, by Disease Indication USD Million (2018-2023)
  • Table 83. Netherlands CBD Oil, by Type USD Million (2018-2023)
  • Table 84. Netherlands CBD Oil, by Application USD Million (2018-2023)
  • Table 85. Netherlands CBD Oil, by Distribution Channel USD Million (2018-2023)
  • Table 86. Netherlands CBD Oil, by Disease Indication USD Million (2018-2023)
  • Table 87. Rest of Europe CBD Oil, by Type USD Million (2018-2023)
  • Table 88. Rest of Europe CBD Oil, by Application USD Million (2018-2023)
  • Table 89. Rest of Europe CBD Oil, by Distribution Channel USD Million (2018-2023)
  • Table 90. Rest of Europe CBD Oil, by Disease Indication USD Million (2018-2023)
  • Table 91. MEA CBD Oil, by Country USD Million (2018-2023)
  • Table 92. MEA CBD Oil, by Type USD Million (2018-2023)
  • Table 93. MEA CBD Oil, by Application USD Million (2018-2023)
  • Table 94. MEA CBD Oil, by Distribution Channel USD Million (2018-2023)
  • Table 95. MEA CBD Oil, by Disease Indication USD Million (2018-2023)
  • Table 96. Middle East CBD Oil, by Type USD Million (2018-2023)
  • Table 97. Middle East CBD Oil, by Application USD Million (2018-2023)
  • Table 98. Middle East CBD Oil, by Distribution Channel USD Million (2018-2023)
  • Table 99. Middle East CBD Oil, by Disease Indication USD Million (2018-2023)
  • Table 100. Africa CBD Oil, by Type USD Million (2018-2023)
  • Table 101. Africa CBD Oil, by Application USD Million (2018-2023)
  • Table 102. Africa CBD Oil, by Distribution Channel USD Million (2018-2023)
  • Table 103. Africa CBD Oil, by Disease Indication USD Million (2018-2023)
  • Table 104. North America CBD Oil, by Country USD Million (2018-2023)
  • Table 105. North America CBD Oil, by Type USD Million (2018-2023)
  • Table 106. North America CBD Oil, by Application USD Million (2018-2023)
  • Table 107. North America CBD Oil, by Distribution Channel USD Million (2018-2023)
  • Table 108. North America CBD Oil, by Disease Indication USD Million (2018-2023)
  • Table 109. United States CBD Oil, by Type USD Million (2018-2023)
  • Table 110. United States CBD Oil, by Application USD Million (2018-2023)
  • Table 111. United States CBD Oil, by Distribution Channel USD Million (2018-2023)
  • Table 112. United States CBD Oil, by Disease Indication USD Million (2018-2023)
  • Table 113. Canada CBD Oil, by Type USD Million (2018-2023)
  • Table 114. Canada CBD Oil, by Application USD Million (2018-2023)
  • Table 115. Canada CBD Oil, by Distribution Channel USD Million (2018-2023)
  • Table 116. Canada CBD Oil, by Disease Indication USD Million (2018-2023)
  • Table 117. Mexico CBD Oil, by Type USD Million (2018-2023)
  • Table 118. Mexico CBD Oil, by Application USD Million (2018-2023)
  • Table 119. Mexico CBD Oil, by Distribution Channel USD Million (2018-2023)
  • Table 120. Mexico CBD Oil, by Disease Indication USD Million (2018-2023)
  • Table 121. CBD Oil Sales: by Type(K Tons)
  • Table 122. CBD Oil Sales Marijuana-Derived CBD Oil Products , by Region K Tons (2018-2023)
  • Table 123. CBD Oil Sales Hemp-Derived CBD Oil Products , by Region K Tons (2018-2023)
  • Table 124. CBD Oil Sales: by Application(K Tons)
  • Table 125. CBD Oil Sales Medical , by Region K Tons (2018-2023)
  • Table 126. CBD Oil Sales Recreational , by Region K Tons (2018-2023)
  • Table 127. CBD Oil Sales: by Distribution Channel(K Tons)
  • Table 128. CBD Oil Sales Hospital Pharmacies , by Region K Tons (2018-2023)
  • Table 129. CBD Oil Sales Retail Pharmacies , by Region K Tons (2018-2023)
  • Table 130. CBD Oil Sales Online Pharmacies , by Region K Tons (2018-2023)
  • Table 131. CBD Oil Sales Others , by Region K Tons (2018-2023)
  • Table 132. South America CBD Oil Sales, by Country K Tons (2018-2023)
  • Table 133. South America CBD Oil Sales, by Type K Tons (2018-2023)
  • Table 134. South America CBD Oil Sales, by Application K Tons (2018-2023)
  • Table 135. South America CBD Oil Sales, by Distribution Channel K Tons (2018-2023)
  • Table 136. South America CBD Oil Sales, by Disease Indication K Tons (2018-2023)
  • Table 137. Brazil CBD Oil Sales, by Type K Tons (2018-2023)
  • Table 138. Brazil CBD Oil Sales, by Application K Tons (2018-2023)
  • Table 139. Brazil CBD Oil Sales, by Distribution Channel K Tons (2018-2023)
  • Table 140. Brazil CBD Oil Sales, by Disease Indication K Tons (2018-2023)
  • Table 141. Argentina CBD Oil Sales, by Type K Tons (2018-2023)
  • Table 142. Argentina CBD Oil Sales, by Application K Tons (2018-2023)
  • Table 143. Argentina CBD Oil Sales, by Distribution Channel K Tons (2018-2023)
  • Table 144. Argentina CBD Oil Sales, by Disease Indication K Tons (2018-2023)
  • Table 145. Rest of South America CBD Oil Sales, by Type K Tons (2018-2023)
  • Table 146. Rest of South America CBD Oil Sales, by Application K Tons (2018-2023)
  • Table 147. Rest of South America CBD Oil Sales, by Distribution Channel K Tons (2018-2023)
  • Table 148. Rest of South America CBD Oil Sales, by Disease Indication K Tons (2018-2023)
  • Table 149. Asia Pacific CBD Oil Sales, by Country K Tons (2018-2023)
  • Table 150. Asia Pacific CBD Oil Sales, by Type K Tons (2018-2023)
  • Table 151. Asia Pacific CBD Oil Sales, by Application K Tons (2018-2023)
  • Table 152. Asia Pacific CBD Oil Sales, by Distribution Channel K Tons (2018-2023)
  • Table 153. Asia Pacific CBD Oil Sales, by Disease Indication K Tons (2018-2023)
  • Table 154. China CBD Oil Sales, by Type K Tons (2018-2023)
  • Table 155. China CBD Oil Sales, by Application K Tons (2018-2023)
  • Table 156. China CBD Oil Sales, by Distribution Channel K Tons (2018-2023)
  • Table 157. China CBD Oil Sales, by Disease Indication K Tons (2018-2023)
  • Table 158. Japan CBD Oil Sales, by Type K Tons (2018-2023)
  • Table 159. Japan CBD Oil Sales, by Application K Tons (2018-2023)
  • Table 160. Japan CBD Oil Sales, by Distribution Channel K Tons (2018-2023)
  • Table 161. Japan CBD Oil Sales, by Disease Indication K Tons (2018-2023)
  • Table 162. India CBD Oil Sales, by Type K Tons (2018-2023)
  • Table 163. India CBD Oil Sales, by Application K Tons (2018-2023)
  • Table 164. India CBD Oil Sales, by Distribution Channel K Tons (2018-2023)
  • Table 165. India CBD Oil Sales, by Disease Indication K Tons (2018-2023)
  • Table 166. South Korea CBD Oil Sales, by Type K Tons (2018-2023)
  • Table 167. South Korea CBD Oil Sales, by Application K Tons (2018-2023)
  • Table 168. South Korea CBD Oil Sales, by Distribution Channel K Tons (2018-2023)
  • Table 169. South Korea CBD Oil Sales, by Disease Indication K Tons (2018-2023)
  • Table 170. Taiwan CBD Oil Sales, by Type K Tons (2018-2023)
  • Table 171. Taiwan CBD Oil Sales, by Application K Tons (2018-2023)
  • Table 172. Taiwan CBD Oil Sales, by Distribution Channel K Tons (2018-2023)
  • Table 173. Taiwan CBD Oil Sales, by Disease Indication K Tons (2018-2023)
  • Table 174. Australia CBD Oil Sales, by Type K Tons (2018-2023)
  • Table 175. Australia CBD Oil Sales, by Application K Tons (2018-2023)
  • Table 176. Australia CBD Oil Sales, by Distribution Channel K Tons (2018-2023)
  • Table 177. Australia CBD Oil Sales, by Disease Indication K Tons (2018-2023)
  • Table 178. Rest of Asia-Pacific CBD Oil Sales, by Type K Tons (2018-2023)
  • Table 179. Rest of Asia-Pacific CBD Oil Sales, by Application K Tons (2018-2023)
  • Table 180. Rest of Asia-Pacific CBD Oil Sales, by Distribution Channel K Tons (2018-2023)
  • Table 181. Rest of Asia-Pacific CBD Oil Sales, by Disease Indication K Tons (2018-2023)
  • Table 182. Europe CBD Oil Sales, by Country K Tons (2018-2023)
  • Table 183. Europe CBD Oil Sales, by Type K Tons (2018-2023)
  • Table 184. Europe CBD Oil Sales, by Application K Tons (2018-2023)
  • Table 185. Europe CBD Oil Sales, by Distribution Channel K Tons (2018-2023)
  • Table 186. Europe CBD Oil Sales, by Disease Indication K Tons (2018-2023)
  • Table 187. Germany CBD Oil Sales, by Type K Tons (2018-2023)
  • Table 188. Germany CBD Oil Sales, by Application K Tons (2018-2023)
  • Table 189. Germany CBD Oil Sales, by Distribution Channel K Tons (2018-2023)
  • Table 190. Germany CBD Oil Sales, by Disease Indication K Tons (2018-2023)
  • Table 191. France CBD Oil Sales, by Type K Tons (2018-2023)
  • Table 192. France CBD Oil Sales, by Application K Tons (2018-2023)
  • Table 193. France CBD Oil Sales, by Distribution Channel K Tons (2018-2023)
  • Table 194. France CBD Oil Sales, by Disease Indication K Tons (2018-2023)
  • Table 195. Italy CBD Oil Sales, by Type K Tons (2018-2023)
  • Table 196. Italy CBD Oil Sales, by Application K Tons (2018-2023)
  • Table 197. Italy CBD Oil Sales, by Distribution Channel K Tons (2018-2023)
  • Table 198. Italy CBD Oil Sales, by Disease Indication K Tons (2018-2023)
  • Table 199. United Kingdom CBD Oil Sales, by Type K Tons (2018-2023)
  • Table 200. United Kingdom CBD Oil Sales, by Application K Tons (2018-2023)
  • Table 201. United Kingdom CBD Oil Sales, by Distribution Channel K Tons (2018-2023)
  • Table 202. United Kingdom CBD Oil Sales, by Disease Indication K Tons (2018-2023)
  • Table 203. Netherlands CBD Oil Sales, by Type K Tons (2018-2023)
  • Table 204. Netherlands CBD Oil Sales, by Application K Tons (2018-2023)
  • Table 205. Netherlands CBD Oil Sales, by Distribution Channel K Tons (2018-2023)
  • Table 206. Netherlands CBD Oil Sales, by Disease Indication K Tons (2018-2023)
  • Table 207. Rest of Europe CBD Oil Sales, by Type K Tons (2018-2023)
  • Table 208. Rest of Europe CBD Oil Sales, by Application K Tons (2018-2023)
  • Table 209. Rest of Europe CBD Oil Sales, by Distribution Channel K Tons (2018-2023)
  • Table 210. Rest of Europe CBD Oil Sales, by Disease Indication K Tons (2018-2023)
  • Table 211. MEA CBD Oil Sales, by Country K Tons (2018-2023)
  • Table 212. MEA CBD Oil Sales, by Type K Tons (2018-2023)
  • Table 213. MEA CBD Oil Sales, by Application K Tons (2018-2023)
  • Table 214. MEA CBD Oil Sales, by Distribution Channel K Tons (2018-2023)
  • Table 215. MEA CBD Oil Sales, by Disease Indication K Tons (2018-2023)
  • Table 216. Middle East CBD Oil Sales, by Type K Tons (2018-2023)
  • Table 217. Middle East CBD Oil Sales, by Application K Tons (2018-2023)
  • Table 218. Middle East CBD Oil Sales, by Distribution Channel K Tons (2018-2023)
  • Table 219. Middle East CBD Oil Sales, by Disease Indication K Tons (2018-2023)
  • Table 220. Africa CBD Oil Sales, by Type K Tons (2018-2023)
  • Table 221. Africa CBD Oil Sales, by Application K Tons (2018-2023)
  • Table 222. Africa CBD Oil Sales, by Distribution Channel K Tons (2018-2023)
  • Table 223. Africa CBD Oil Sales, by Disease Indication K Tons (2018-2023)
  • Table 224. North America CBD Oil Sales, by Country K Tons (2018-2023)
  • Table 225. North America CBD Oil Sales, by Type K Tons (2018-2023)
  • Table 226. North America CBD Oil Sales, by Application K Tons (2018-2023)
  • Table 227. North America CBD Oil Sales, by Distribution Channel K Tons (2018-2023)
  • Table 228. North America CBD Oil Sales, by Disease Indication K Tons (2018-2023)
  • Table 229. United States CBD Oil Sales, by Type K Tons (2018-2023)
  • Table 230. United States CBD Oil Sales, by Application K Tons (2018-2023)
  • Table 231. United States CBD Oil Sales, by Distribution Channel K Tons (2018-2023)
  • Table 232. United States CBD Oil Sales, by Disease Indication K Tons (2018-2023)
  • Table 233. Canada CBD Oil Sales, by Type K Tons (2018-2023)
  • Table 234. Canada CBD Oil Sales, by Application K Tons (2018-2023)
  • Table 235. Canada CBD Oil Sales, by Distribution Channel K Tons (2018-2023)
  • Table 236. Canada CBD Oil Sales, by Disease Indication K Tons (2018-2023)
  • Table 237. Mexico CBD Oil Sales, by Type K Tons (2018-2023)
  • Table 238. Mexico CBD Oil Sales, by Application K Tons (2018-2023)
  • Table 239. Mexico CBD Oil Sales, by Distribution Channel K Tons (2018-2023)
  • Table 240. Mexico CBD Oil Sales, by Disease Indication K Tons (2018-2023)
  • Table 241. CBD Oil: by Type(USD/Units)
  • Table 242. Company Basic Information, Sales Area and Its Competitors
  • Table 243. Company Basic Information, Sales Area and Its Competitors
  • Table 244. Company Basic Information, Sales Area and Its Competitors
  • Table 245. Company Basic Information, Sales Area and Its Competitors
  • Table 246. Company Basic Information, Sales Area and Its Competitors
  • Table 247. Company Basic Information, Sales Area and Its Competitors
  • Table 248. Company Basic Information, Sales Area and Its Competitors
  • Table 249. Company Basic Information, Sales Area and Its Competitors
  • Table 250. Company Basic Information, Sales Area and Its Competitors
  • Table 251. Company Basic Information, Sales Area and Its Competitors
  • Table 252. CBD Oil: by Type(USD Million)
  • Table 253. CBD Oil Marijuana-Derived CBD Oil Products , by Region USD Million (2025-2030)
  • Table 254. CBD Oil Hemp-Derived CBD Oil Products , by Region USD Million (2025-2030)
  • Table 255. CBD Oil: by Application(USD Million)
  • Table 256. CBD Oil Medical , by Region USD Million (2025-2030)
  • Table 257. CBD Oil Recreational , by Region USD Million (2025-2030)
  • Table 258. CBD Oil: by Distribution Channel(USD Million)
  • Table 259. CBD Oil Hospital Pharmacies , by Region USD Million (2025-2030)
  • Table 260. CBD Oil Retail Pharmacies , by Region USD Million (2025-2030)
  • Table 261. CBD Oil Online Pharmacies , by Region USD Million (2025-2030)
  • Table 262. CBD Oil Others , by Region USD Million (2025-2030)
  • Table 263. South America CBD Oil, by Country USD Million (2025-2030)
  • Table 264. South America CBD Oil, by Type USD Million (2025-2030)
  • Table 265. South America CBD Oil, by Application USD Million (2025-2030)
  • Table 266. South America CBD Oil, by Distribution Channel USD Million (2025-2030)
  • Table 267. South America CBD Oil, by Disease Indication USD Million (2025-2030)
  • Table 268. Brazil CBD Oil, by Type USD Million (2025-2030)
  • Table 269. Brazil CBD Oil, by Application USD Million (2025-2030)
  • Table 270. Brazil CBD Oil, by Distribution Channel USD Million (2025-2030)
  • Table 271. Brazil CBD Oil, by Disease Indication USD Million (2025-2030)
  • Table 272. Argentina CBD Oil, by Type USD Million (2025-2030)
  • Table 273. Argentina CBD Oil, by Application USD Million (2025-2030)
  • Table 274. Argentina CBD Oil, by Distribution Channel USD Million (2025-2030)
  • Table 275. Argentina CBD Oil, by Disease Indication USD Million (2025-2030)
  • Table 276. Rest of South America CBD Oil, by Type USD Million (2025-2030)
  • Table 277. Rest of South America CBD Oil, by Application USD Million (2025-2030)
  • Table 278. Rest of South America CBD Oil, by Distribution Channel USD Million (2025-2030)
  • Table 279. Rest of South America CBD Oil, by Disease Indication USD Million (2025-2030)
  • Table 280. Asia Pacific CBD Oil, by Country USD Million (2025-2030)
  • Table 281. Asia Pacific CBD Oil, by Type USD Million (2025-2030)
  • Table 282. Asia Pacific CBD Oil, by Application USD Million (2025-2030)
  • Table 283. Asia Pacific CBD Oil, by Distribution Channel USD Million (2025-2030)
  • Table 284. Asia Pacific CBD Oil, by Disease Indication USD Million (2025-2030)
  • Table 285. China CBD Oil, by Type USD Million (2025-2030)
  • Table 286. China CBD Oil, by Application USD Million (2025-2030)
  • Table 287. China CBD Oil, by Distribution Channel USD Million (2025-2030)
  • Table 288. China CBD Oil, by Disease Indication USD Million (2025-2030)
  • Table 289. Japan CBD Oil, by Type USD Million (2025-2030)
  • Table 290. Japan CBD Oil, by Application USD Million (2025-2030)
  • Table 291. Japan CBD Oil, by Distribution Channel USD Million (2025-2030)
  • Table 292. Japan CBD Oil, by Disease Indication USD Million (2025-2030)
  • Table 293. India CBD Oil, by Type USD Million (2025-2030)
  • Table 294. India CBD Oil, by Application USD Million (2025-2030)
  • Table 295. India CBD Oil, by Distribution Channel USD Million (2025-2030)
  • Table 296. India CBD Oil, by Disease Indication USD Million (2025-2030)
  • Table 297. South Korea CBD Oil, by Type USD Million (2025-2030)
  • Table 298. South Korea CBD Oil, by Application USD Million (2025-2030)
  • Table 299. South Korea CBD Oil, by Distribution Channel USD Million (2025-2030)
  • Table 300. South Korea CBD Oil, by Disease Indication USD Million (2025-2030)
  • Table 301. Taiwan CBD Oil, by Type USD Million (2025-2030)
  • Table 302. Taiwan CBD Oil, by Application USD Million (2025-2030)
  • Table 303. Taiwan CBD Oil, by Distribution Channel USD Million (2025-2030)
  • Table 304. Taiwan CBD Oil, by Disease Indication USD Million (2025-2030)
  • Table 305. Australia CBD Oil, by Type USD Million (2025-2030)
  • Table 306. Australia CBD Oil, by Application USD Million (2025-2030)
  • Table 307. Australia CBD Oil, by Distribution Channel USD Million (2025-2030)
  • Table 308. Australia CBD Oil, by Disease Indication USD Million (2025-2030)
  • Table 309. Rest of Asia-Pacific CBD Oil, by Type USD Million (2025-2030)
  • Table 310. Rest of Asia-Pacific CBD Oil, by Application USD Million (2025-2030)
  • Table 311. Rest of Asia-Pacific CBD Oil, by Distribution Channel USD Million (2025-2030)
  • Table 312. Rest of Asia-Pacific CBD Oil, by Disease Indication USD Million (2025-2030)
  • Table 313. Europe CBD Oil, by Country USD Million (2025-2030)
  • Table 314. Europe CBD Oil, by Type USD Million (2025-2030)
  • Table 315. Europe CBD Oil, by Application USD Million (2025-2030)
  • Table 316. Europe CBD Oil, by Distribution Channel USD Million (2025-2030)
  • Table 317. Europe CBD Oil, by Disease Indication USD Million (2025-2030)
  • Table 318. Germany CBD Oil, by Type USD Million (2025-2030)
  • Table 319. Germany CBD Oil, by Application USD Million (2025-2030)
  • Table 320. Germany CBD Oil, by Distribution Channel USD Million (2025-2030)
  • Table 321. Germany CBD Oil, by Disease Indication USD Million (2025-2030)
  • Table 322. France CBD Oil, by Type USD Million (2025-2030)
  • Table 323. France CBD Oil, by Application USD Million (2025-2030)
  • Table 324. France CBD Oil, by Distribution Channel USD Million (2025-2030)
  • Table 325. France CBD Oil, by Disease Indication USD Million (2025-2030)
  • Table 326. Italy CBD Oil, by Type USD Million (2025-2030)
  • Table 327. Italy CBD Oil, by Application USD Million (2025-2030)
  • Table 328. Italy CBD Oil, by Distribution Channel USD Million (2025-2030)
  • Table 329. Italy CBD Oil, by Disease Indication USD Million (2025-2030)
  • Table 330. United Kingdom CBD Oil, by Type USD Million (2025-2030)
  • Table 331. United Kingdom CBD Oil, by Application USD Million (2025-2030)
  • Table 332. United Kingdom CBD Oil, by Distribution Channel USD Million (2025-2030)
  • Table 333. United Kingdom CBD Oil, by Disease Indication USD Million (2025-2030)
  • Table 334. Netherlands CBD Oil, by Type USD Million (2025-2030)
  • Table 335. Netherlands CBD Oil, by Application USD Million (2025-2030)
  • Table 336. Netherlands CBD Oil, by Distribution Channel USD Million (2025-2030)
  • Table 337. Netherlands CBD Oil, by Disease Indication USD Million (2025-2030)
  • Table 338. Rest of Europe CBD Oil, by Type USD Million (2025-2030)
  • Table 339. Rest of Europe CBD Oil, by Application USD Million (2025-2030)
  • Table 340. Rest of Europe CBD Oil, by Distribution Channel USD Million (2025-2030)
  • Table 341. Rest of Europe CBD Oil, by Disease Indication USD Million (2025-2030)
  • Table 342. MEA CBD Oil, by Country USD Million (2025-2030)
  • Table 343. MEA CBD Oil, by Type USD Million (2025-2030)
  • Table 344. MEA CBD Oil, by Application USD Million (2025-2030)
  • Table 345. MEA CBD Oil, by Distribution Channel USD Million (2025-2030)
  • Table 346. MEA CBD Oil, by Disease Indication USD Million (2025-2030)
  • Table 347. Middle East CBD Oil, by Type USD Million (2025-2030)
  • Table 348. Middle East CBD Oil, by Application USD Million (2025-2030)
  • Table 349. Middle East CBD Oil, by Distribution Channel USD Million (2025-2030)
  • Table 350. Middle East CBD Oil, by Disease Indication USD Million (2025-2030)
  • Table 351. Africa CBD Oil, by Type USD Million (2025-2030)
  • Table 352. Africa CBD Oil, by Application USD Million (2025-2030)
  • Table 353. Africa CBD Oil, by Distribution Channel USD Million (2025-2030)
  • Table 354. Africa CBD Oil, by Disease Indication USD Million (2025-2030)
  • Table 355. North America CBD Oil, by Country USD Million (2025-2030)
  • Table 356. North America CBD Oil, by Type USD Million (2025-2030)
  • Table 357. North America CBD Oil, by Application USD Million (2025-2030)
  • Table 358. North America CBD Oil, by Distribution Channel USD Million (2025-2030)
  • Table 359. North America CBD Oil, by Disease Indication USD Million (2025-2030)
  • Table 360. United States CBD Oil, by Type USD Million (2025-2030)
  • Table 361. United States CBD Oil, by Application USD Million (2025-2030)
  • Table 362. United States CBD Oil, by Distribution Channel USD Million (2025-2030)
  • Table 363. United States CBD Oil, by Disease Indication USD Million (2025-2030)
  • Table 364. Canada CBD Oil, by Type USD Million (2025-2030)
  • Table 365. Canada CBD Oil, by Application USD Million (2025-2030)
  • Table 366. Canada CBD Oil, by Distribution Channel USD Million (2025-2030)
  • Table 367. Canada CBD Oil, by Disease Indication USD Million (2025-2030)
  • Table 368. Mexico CBD Oil, by Type USD Million (2025-2030)
  • Table 369. Mexico CBD Oil, by Application USD Million (2025-2030)
  • Table 370. Mexico CBD Oil, by Distribution Channel USD Million (2025-2030)
  • Table 371. Mexico CBD Oil, by Disease Indication USD Million (2025-2030)
  • Table 372. CBD Oil Sales: by Type(K Tons)
  • Table 373. CBD Oil Sales Marijuana-Derived CBD Oil Products , by Region K Tons (2025-2030)
  • Table 374. CBD Oil Sales Hemp-Derived CBD Oil Products , by Region K Tons (2025-2030)
  • Table 375. CBD Oil Sales: by Application(K Tons)
  • Table 376. CBD Oil Sales Medical , by Region K Tons (2025-2030)
  • Table 377. CBD Oil Sales Recreational , by Region K Tons (2025-2030)
  • Table 378. CBD Oil Sales: by Distribution Channel(K Tons)
  • Table 379. CBD Oil Sales Hospital Pharmacies , by Region K Tons (2025-2030)
  • Table 380. CBD Oil Sales Retail Pharmacies , by Region K Tons (2025-2030)
  • Table 381. CBD Oil Sales Online Pharmacies , by Region K Tons (2025-2030)
  • Table 382. CBD Oil Sales Others , by Region K Tons (2025-2030)
  • Table 383. South America CBD Oil Sales, by Country K Tons (2025-2030)
  • Table 384. South America CBD Oil Sales, by Type K Tons (2025-2030)
  • Table 385. South America CBD Oil Sales, by Application K Tons (2025-2030)
  • Table 386. South America CBD Oil Sales, by Distribution Channel K Tons (2025-2030)
  • Table 387. South America CBD Oil Sales, by Disease Indication K Tons (2025-2030)
  • Table 388. Brazil CBD Oil Sales, by Type K Tons (2025-2030)
  • Table 389. Brazil CBD Oil Sales, by Application K Tons (2025-2030)
  • Table 390. Brazil CBD Oil Sales, by Distribution Channel K Tons (2025-2030)
  • Table 391. Brazil CBD Oil Sales, by Disease Indication K Tons (2025-2030)
  • Table 392. Argentina CBD Oil Sales, by Type K Tons (2025-2030)
  • Table 393. Argentina CBD Oil Sales, by Application K Tons (2025-2030)
  • Table 394. Argentina CBD Oil Sales, by Distribution Channel K Tons (2025-2030)
  • Table 395. Argentina CBD Oil Sales, by Disease Indication K Tons (2025-2030)
  • Table 396. Rest of South America CBD Oil Sales, by Type K Tons (2025-2030)
  • Table 397. Rest of South America CBD Oil Sales, by Application K Tons (2025-2030)
  • Table 398. Rest of South America CBD Oil Sales, by Distribution Channel K Tons (2025-2030)
  • Table 399. Rest of South America CBD Oil Sales, by Disease Indication K Tons (2025-2030)
  • Table 400. Asia Pacific CBD Oil Sales, by Country K Tons (2025-2030)
  • Table 401. Asia Pacific CBD Oil Sales, by Type K Tons (2025-2030)
  • Table 402. Asia Pacific CBD Oil Sales, by Application K Tons (2025-2030)
  • Table 403. Asia Pacific CBD Oil Sales, by Distribution Channel K Tons (2025-2030)
  • Table 404. Asia Pacific CBD Oil Sales, by Disease Indication K Tons (2025-2030)
  • Table 405. China CBD Oil Sales, by Type K Tons (2025-2030)
  • Table 406. China CBD Oil Sales, by Application K Tons (2025-2030)
  • Table 407. China CBD Oil Sales, by Distribution Channel K Tons (2025-2030)
  • Table 408. China CBD Oil Sales, by Disease Indication K Tons (2025-2030)
  • Table 409. Japan CBD Oil Sales, by Type K Tons (2025-2030)
  • Table 410. Japan CBD Oil Sales, by Application K Tons (2025-2030)
  • Table 411. Japan CBD Oil Sales, by Distribution Channel K Tons (2025-2030)
  • Table 412. Japan CBD Oil Sales, by Disease Indication K Tons (2025-2030)
  • Table 413. India CBD Oil Sales, by Type K Tons (2025-2030)
  • Table 414. India CBD Oil Sales, by Application K Tons (2025-2030)
  • Table 415. India CBD Oil Sales, by Distribution Channel K Tons (2025-2030)
  • Table 416. India CBD Oil Sales, by Disease Indication K Tons (2025-2030)
  • Table 417. South Korea CBD Oil Sales, by Type K Tons (2025-2030)
  • Table 418. South Korea CBD Oil Sales, by Application K Tons (2025-2030)
  • Table 419. South Korea CBD Oil Sales, by Distribution Channel K Tons (2025-2030)
  • Table 420. South Korea CBD Oil Sales, by Disease Indication K Tons (2025-2030)
  • Table 421. Taiwan CBD Oil Sales, by Type K Tons (2025-2030)
  • Table 422. Taiwan CBD Oil Sales, by Application K Tons (2025-2030)
  • Table 423. Taiwan CBD Oil Sales, by Distribution Channel K Tons (2025-2030)
  • Table 424. Taiwan CBD Oil Sales, by Disease Indication K Tons (2025-2030)
  • Table 425. Australia CBD Oil Sales, by Type K Tons (2025-2030)
  • Table 426. Australia CBD Oil Sales, by Application K Tons (2025-2030)
  • Table 427. Australia CBD Oil Sales, by Distribution Channel K Tons (2025-2030)
  • Table 428. Australia CBD Oil Sales, by Disease Indication K Tons (2025-2030)
  • Table 429. Rest of Asia-Pacific CBD Oil Sales, by Type K Tons (2025-2030)
  • Table 430. Rest of Asia-Pacific CBD Oil Sales, by Application K Tons (2025-2030)
  • Table 431. Rest of Asia-Pacific CBD Oil Sales, by Distribution Channel K Tons (2025-2030)
  • Table 432. Rest of Asia-Pacific CBD Oil Sales, by Disease Indication K Tons (2025-2030)
  • Table 433. Europe CBD Oil Sales, by Country K Tons (2025-2030)
  • Table 434. Europe CBD Oil Sales, by Type K Tons (2025-2030)
  • Table 435. Europe CBD Oil Sales, by Application K Tons (2025-2030)
  • Table 436. Europe CBD Oil Sales, by Distribution Channel K Tons (2025-2030)
  • Table 437. Europe CBD Oil Sales, by Disease Indication K Tons (2025-2030)
  • Table 438. Germany CBD Oil Sales, by Type K Tons (2025-2030)
  • Table 439. Germany CBD Oil Sales, by Application K Tons (2025-2030)
  • Table 440. Germany CBD Oil Sales, by Distribution Channel K Tons (2025-2030)
  • Table 441. Germany CBD Oil Sales, by Disease Indication K Tons (2025-2030)
  • Table 442. France CBD Oil Sales, by Type K Tons (2025-2030)
  • Table 443. France CBD Oil Sales, by Application K Tons (2025-2030)
  • Table 444. France CBD Oil Sales, by Distribution Channel K Tons (2025-2030)
  • Table 445. France CBD Oil Sales, by Disease Indication K Tons (2025-2030)
  • Table 446. Italy CBD Oil Sales, by Type K Tons (2025-2030)
  • Table 447. Italy CBD Oil Sales, by Application K Tons (2025-2030)
  • Table 448. Italy CBD Oil Sales, by Distribution Channel K Tons (2025-2030)
  • Table 449. Italy CBD Oil Sales, by Disease Indication K Tons (2025-2030)
  • Table 450. United Kingdom CBD Oil Sales, by Type K Tons (2025-2030)
  • Table 451. United Kingdom CBD Oil Sales, by Application K Tons (2025-2030)
  • Table 452. United Kingdom CBD Oil Sales, by Distribution Channel K Tons (2025-2030)
  • Table 453. United Kingdom CBD Oil Sales, by Disease Indication K Tons (2025-2030)
  • Table 454. Netherlands CBD Oil Sales, by Type K Tons (2025-2030)
  • Table 455. Netherlands CBD Oil Sales, by Application K Tons (2025-2030)
  • Table 456. Netherlands CBD Oil Sales, by Distribution Channel K Tons (2025-2030)
  • Table 457. Netherlands CBD Oil Sales, by Disease Indication K Tons (2025-2030)
  • Table 458. Rest of Europe CBD Oil Sales, by Type K Tons (2025-2030)
  • Table 459. Rest of Europe CBD Oil Sales, by Application K Tons (2025-2030)
  • Table 460. Rest of Europe CBD Oil Sales, by Distribution Channel K Tons (2025-2030)
  • Table 461. Rest of Europe CBD Oil Sales, by Disease Indication K Tons (2025-2030)
  • Table 462. MEA CBD Oil Sales, by Country K Tons (2025-2030)
  • Table 463. MEA CBD Oil Sales, by Type K Tons (2025-2030)
  • Table 464. MEA CBD Oil Sales, by Application K Tons (2025-2030)
  • Table 465. MEA CBD Oil Sales, by Distribution Channel K Tons (2025-2030)
  • Table 466. MEA CBD Oil Sales, by Disease Indication K Tons (2025-2030)
  • Table 467. Middle East CBD Oil Sales, by Type K Tons (2025-2030)
  • Table 468. Middle East CBD Oil Sales, by Application K Tons (2025-2030)
  • Table 469. Middle East CBD Oil Sales, by Distribution Channel K Tons (2025-2030)
  • Table 470. Middle East CBD Oil Sales, by Disease Indication K Tons (2025-2030)
  • Table 471. Africa CBD Oil Sales, by Type K Tons (2025-2030)
  • Table 472. Africa CBD Oil Sales, by Application K Tons (2025-2030)
  • Table 473. Africa CBD Oil Sales, by Distribution Channel K Tons (2025-2030)
  • Table 474. Africa CBD Oil Sales, by Disease Indication K Tons (2025-2030)
  • Table 475. North America CBD Oil Sales, by Country K Tons (2025-2030)
  • Table 476. North America CBD Oil Sales, by Type K Tons (2025-2030)
  • Table 477. North America CBD Oil Sales, by Application K Tons (2025-2030)
  • Table 478. North America CBD Oil Sales, by Distribution Channel K Tons (2025-2030)
  • Table 479. North America CBD Oil Sales, by Disease Indication K Tons (2025-2030)
  • Table 480. United States CBD Oil Sales, by Type K Tons (2025-2030)
  • Table 481. United States CBD Oil Sales, by Application K Tons (2025-2030)
  • Table 482. United States CBD Oil Sales, by Distribution Channel K Tons (2025-2030)
  • Table 483. United States CBD Oil Sales, by Disease Indication K Tons (2025-2030)
  • Table 484. Canada CBD Oil Sales, by Type K Tons (2025-2030)
  • Table 485. Canada CBD Oil Sales, by Application K Tons (2025-2030)
  • Table 486. Canada CBD Oil Sales, by Distribution Channel K Tons (2025-2030)
  • Table 487. Canada CBD Oil Sales, by Disease Indication K Tons (2025-2030)
  • Table 488. Mexico CBD Oil Sales, by Type K Tons (2025-2030)
  • Table 489. Mexico CBD Oil Sales, by Application K Tons (2025-2030)
  • Table 490. Mexico CBD Oil Sales, by Distribution Channel K Tons (2025-2030)
  • Table 491. Mexico CBD Oil Sales, by Disease Indication K Tons (2025-2030)
  • Table 492. CBD Oil: by Type(USD/Units)
  • Table 493. Research Programs/Design for This Report
  • Table 494. Key Data Information from Secondary Sources
  • Table 495. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global CBD Oil: by Type USD Million (2018-2023)
  • Figure 5. Global CBD Oil: by Application USD Million (2018-2023)
  • Figure 6. Global CBD Oil: by Distribution Channel USD Million (2018-2023)
  • Figure 7. South America CBD Oil Share (%), by Country
  • Figure 8. Asia Pacific CBD Oil Share (%), by Country
  • Figure 9. Europe CBD Oil Share (%), by Country
  • Figure 10. MEA CBD Oil Share (%), by Country
  • Figure 11. North America CBD Oil Share (%), by Country
  • Figure 12. Global CBD Oil: by Type K Tons (2018-2023)
  • Figure 13. Global CBD Oil: by Application K Tons (2018-2023)
  • Figure 14. Global CBD Oil: by Distribution Channel K Tons (2018-2023)
  • Figure 15. South America CBD Oil Share (%), by Country
  • Figure 16. Asia Pacific CBD Oil Share (%), by Country
  • Figure 17. Europe CBD Oil Share (%), by Country
  • Figure 18. MEA CBD Oil Share (%), by Country
  • Figure 19. North America CBD Oil Share (%), by Country
  • Figure 20. Global CBD Oil: by Type USD/Units (2018-2023)
  • Figure 21. Global CBD Oil share by Players 2023 (%)
  • Figure 22. Global CBD Oil share by Players (Top 3) 2023(%)
  • Figure 23. Global CBD Oil share by Players (Top 5) 2023(%)
  • Figure 24. BCG Matrix for key Companies
  • Figure 25. ENDOCA BV (Netherlands) Revenue, Net Income and Gross profit
  • Figure 26. ENDOCA BV (Netherlands) Revenue: by Geography 2023
  • Figure 27. Isodiol International Inc. (Canada) Revenue, Net Income and Gross profit
  • Figure 28. Isodiol International Inc. (Canada) Revenue: by Geography 2023
  • Figure 29. Medical Marijuana Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 30. Medical Marijuana Inc. (United States) Revenue: by Geography 2023
  • Figure 31. Aurora Cannabis Inc. (Canada) Revenue, Net Income and Gross profit
  • Figure 32. Aurora Cannabis Inc. (Canada) Revenue: by Geography 2023
  • Figure 33. CBD American Shaman (United States) Revenue, Net Income and Gross profit
  • Figure 34. CBD American Shaman (United States) Revenue: by Geography 2023
  • Figure 35. Elixinol LLC (United States) Revenue, Net Income and Gross profit
  • Figure 36. Elixinol LLC (United States) Revenue: by Geography 2023
  • Figure 37. FOLIUM BIOSCIENCES (United States) Revenue, Net Income and Gross profit
  • Figure 38. FOLIUM BIOSCIENCES (United States) Revenue: by Geography 2023
  • Figure 39. Freedom Leaf Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 40. Freedom Leaf Inc. (United States) Revenue: by Geography 2023
  • Figure 41. NuLeaf Naturals, LLC. (United States) Revenue, Net Income and Gross profit
  • Figure 42. NuLeaf Naturals, LLC. (United States) Revenue: by Geography 2023
  • Figure 43. Charlotte's Web (CWB Holdings, Inc.) (United States) Revenue, Net Income and Gross profit
  • Figure 44. Charlotte's Web (CWB Holdings, Inc.) (United States) Revenue: by Geography 2023
  • Figure 45. Global CBD Oil: by Type USD Million (2025-2030)
  • Figure 46. Global CBD Oil: by Application USD Million (2025-2030)
  • Figure 47. Global CBD Oil: by Distribution Channel USD Million (2025-2030)
  • Figure 48. South America CBD Oil Share (%), by Country
  • Figure 49. Asia Pacific CBD Oil Share (%), by Country
  • Figure 50. Europe CBD Oil Share (%), by Country
  • Figure 51. MEA CBD Oil Share (%), by Country
  • Figure 52. North America CBD Oil Share (%), by Country
  • Figure 53. Global CBD Oil: by Type K Tons (2025-2030)
  • Figure 54. Global CBD Oil: by Application K Tons (2025-2030)
  • Figure 55. Global CBD Oil: by Distribution Channel K Tons (2025-2030)
  • Figure 56. South America CBD Oil Share (%), by Country
  • Figure 57. Asia Pacific CBD Oil Share (%), by Country
  • Figure 58. Europe CBD Oil Share (%), by Country
  • Figure 59. MEA CBD Oil Share (%), by Country
  • Figure 60. North America CBD Oil Share (%), by Country
  • Figure 61. Global CBD Oil: by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • ENDOCA BV (Netherlands)
  • Isodiol International Inc. (Canada)
  • Medical Marijuana Inc. (United States)
  • Aurora Cannabis Inc. (Canada)
  • CBD American Shaman (United States)
  • Elixinol LLC (United States)
  • FOLIUM BIOSCIENCES (United States)
  • Freedom Leaf Inc. (United States)
  • NuLeaf Naturals, LLC. (United States)
  • Charlotte's Web (CWB Holdings, Inc.) (United States)
Additional players considered in the study are as follows:
Green Roads Wellness (United States) , Kazmira LLC (Orochem Technologies) (United States) , CV Sciences, Inc. (United States) , Cannoid LLC (United States) , Canopy Growth Corporation (Canada)
Select User Access Type

Key Highlights of Report


Mar 2024 235 Pages 68 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global CBD Oil Market Quantitative research analysis
Global CBD Oil Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

"Increasing Legalization of Cannabis-Based Products" is seen as one of major influencing trends for CBD Oil Market during projected period 2023-2030.
The Concentration Rate of Global CBD Oil market is highlighted using HHI Index.
Global Players will contribute the maximum growth of Global CBD Oil market throughout the predicted period.
North America holds highest share for CBD Oil Market .

Know More About Global CBD Oil Market Report?

Have a Query? Click Here

Other Related Reports

Contraceptives Comprehensive Study by Type (Oral Contraceptive Pills, Contraceptive Injectable, Topical Contraceptive Patch), Application (Hospitals, Homecare, Gynecology Centers, Clinics, Ambulatory...
$ 3650
Encephalitis Vaccine Comprehensive Study by Application (Child, Adult), End User (Hospitals, Clinics, Vaccination Centers, Others), Strain (Nakayama, Beijing, P-3, SA 14-14-2) Players and Region - Gl...
$ 3500
Medical Marijuana Comprehensive Study by Type (Buds, Oil, Tinctures), Application (Chronic Pain, Mental Disorders, Arthritis, Migraine, Cancer, Other), Marijuana Type (Medical Marijuana, Recreational...
$ 3500
Orphan Drugs Comprehensive Study by Drug Type (Biologics, Non-Biologics), Sale (Generics, Prescribed), Drugs (Revlimid, Rituxan, Opdivo, Others), Disease Type (Oncology, Gastrointestinal, Pulmonary, ...
$ 3750
Diptheria Vaccine Comprehensive Study by Type (Daptacel, Infanrix, Kinrix, Pediarix, Pentacel, Quaracel), Disease Type (Diphtheria, Tetanus, Pertussis), Packaging Type (0.5 ML, 1 ML, 2 ML, Others), A...
$ 3450
Bio-pharma Comprehensive Study by Type (Monoclonal Antibodies, Recombinant Proteins, Granulocyte-Colony Stimulating Factor (G-CSF), Interferons, Recombinant Human Insulin, Erythropoietin, Vaccines, G...
$ 3750